Get template

Features

Benefits

Phlebectomies

Contact

A New Standard in Venous Disease Treatment

Solving the phlebectomy hemostasis gap.

Learn More

35%

Adults in the U.S. have CVD

$4-10B

Spent each year by the US Healthcare System on CVD

$2.6B

Global Varicose Vein Market by 2032

Our Mission:
To design specialty-focused devices that solve unmet clinical needs, support medical professionals and elevate the standard of care in both surgical and clinical environments.

Medical Leadership

As past president of the American Venous Forum, Dr. Pappas has shaped the field through innovation, education, and dedication to patient outcomes.

Dr. Peter Pappas, MD, serves as Chief Medical Officer for H.E.A.L. With over 30 years of clinical and research experience, he is an internationally recognized leader in venous disease.

His expertise guides H.E.A.L.’s mission to set a new clinical standard in phlebectomy treatment and
technology.

Our Solution: A Battery-Operated Bipolar Cuatery Clamp System

Reusable Handle

Interchangeable Tips

Consistent hemostasis.

Battery-operated, rechargeable handle designed for ergonomic single-handed use use during phlebectomy procedures

Disopsable end effectors sized to match vein diameter - grasp tissue, then deliver precise bipolar coagulation

Roadmap

Phase 1: Production Prototype

2026

Phase 2: 510(k) Approval and LMR

Q2 2027

Phase 3: Full Market Release

Q4 2027

Roadmap

Phase 1: Production Prototype

2026

Phase 2: 510(k) Approval and LMR

Q2 2027

Phase 3: Full Market Release

Q4 2027

Roadmap

Phase 1: Production Prototype

2026

Phase 2: 510(k) Approval and LMR

Q2 2027

Phase 3: Full Market Release

Q4 2027

Eliminates the need for a surgical assistant and reduces overall procedure time.

A New Standard in Venous Disease Treatment

A New Standard in Venous Disease Treatment

Solving the phlebectomy hemostasis gap.

Solving the phlebectomy hemostasis gap.

35%

35%

Adults in the U.S. have CVD

Adults in the U.S. have CVD

$4-10B

$4-10B

Spent each year by the US Healthcare System on CVD

Spent each year by the US Healthcare System on CVD

$2.6B

$2.6B

Global Varicose Vein Market by 2032

Our Mission: To design specialty-focused devices that solve unmet clinical needs, support medical professionals and elevate the standard of care in both surgical and clinical environments.

Our Mission: To design specialty-focused devices that solve unmet clinical needs, support medical professionals and elevate the standard of care in both surgical and clinical environments.

Medical Leadership

As past president of the American Venous Forum, Dr. Pappas has shaped the field through innovation, education, and dedication to patient outcomes.

Dr. Peter Pappas, MD, serves as Chief Medical Officer for H.E.A.L. With over 30 years of clinical and research experience, he is an internationally recognized leader in venous disease.

His expertise guides H.E.A.L.’s mission to set a new clinical standard in phlebectomy treatment and technology.

Our Solution: A Battery-Operated Bipolar Cuatery Clamp System

Our Solution: A Battery-Operated Bipolar Cuatery Clamp System

Reusable Handle

Interchangeable Tips

Interchangeable Tips

Consistent hemostasis.

Consistent hemostasis.

Our Mission:
To design specialty-focused devices that solve unmet clinical needs, support medical professionals and elevate the standard of care in both surgical and clinical environments.

Our Mission:
To design specialty-focused devices that solve unmet clinical needs, support medical professionals and elevate the standard of care in both surgical and clinical environments.

His expertise guides H.E.A.L.’s mission to set a new clinical standard in phlebectomy treatment and
technology.